AIFM2 and cancer: In line with this hypothesis, more recently, FSP-1, previously called apoptosis-inducing factor mitochondria associated 2, was identified as a GPX-4 independent ferroptosis suppressor, and pharmacological FSP-1 inhibition strongly synergized with a GPX-4 inhibitor to induce ferroptosis in many cancer cells [27,28].